Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis

Thorax. 2011 Mar;66(3):259-60. doi: 10.1136/thx.2010.156018. Epub 2011 Jan 12.
No abstract available

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Adjuvants, Immunologic
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cystic Fibrosis / immunology*
  • Female
  • Humans
  • Infant
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza Vaccines / immunology*
  • Influenza, Human / prevention & control*
  • Male
  • Polysorbates
  • Squalene / immunology
  • Young Adult

Substances

  • Adjuvants, Immunologic
  • Influenza Vaccines
  • MF59 oil emulsion
  • Polysorbates
  • Squalene